Healthcare

Press Release

Massachusetts General Hospital Selects VTOC for Multi-Center Prostate Cancer Research Study


February 12, 2016 - San Diego, CA

VisionTree®, a leader in cloud-based, patient reported outcomes, patient engagement and multi-center research/registry solutions, announced today via Twitter that Massachusetts General Hospital has chosen to adopt the VisionTree Optimal Care (VTOC) v4.1 platform as its patient portal to deliver patient-reported quality of life assessments for its multi-center prostate cancer research study across several sites.


About VisionTree®

VisionTree Software, Inc. is a leader in cloud-based, patient-centered health electronic medical records, communication and population health data management systems. The VisionTree Optimal Care (VTOC) patient data management and workflow platform is ARRA HITECH Meaningful Use certified for Stage 1 & 2 as a modular EHR and implemented at over 600 sites with 2.5M+ patients.

The VTOC platform is used for multi-center patient/clinical connectivity and research, HIE, ACO and population health initiatives focused in the fields of oncology, neuro/spine surgery, diabetes and wellness. VisionTree's customer base consists of leading academic and community centers, research organizations and medical societies globally including 8 of the top 10 U.S. News and World Report hospitals.

For more information, visit www.visiontree.com or email us at: healthcare@visiontree.com

To learn more about VisionTree Optimal Care, visit: VTOC Clinical